Candel Therapeutics, Inc. (CADL) NASDAQ
8.42
-0.09(-1.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 299.22M |
| Enterprise Value | 181.39M |
| P/E Ratio | -9.65 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.27 |
| Return On Equity | -0.6 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -35.22M |
| Net Income | -38.18M |
| Diluted EPS | -0.72 |
Balance Sheet
| Total Cash | 194.83M |
| Total Cash/Share | 3.12 |
| Total Debt | 1.8M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 28.05 |
| Book Value Per Share | 2.21 |
Price History
| 52-Week Change | 50.63 |
| 52-Week High | 9.27 |
| 52-Week Low | 4.35 |
| Moving Average 50 Days | 6.59 |
| Moving Average 200 Days | 5.72 |
Statistics
| Average Volume | 1.74M |
| Shares Outstanding | 54.9M |
| % Held by Institutions | 82.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
